Cherry Creek Investment Advisors, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Cherry Creek Investment Advisors, Inc.
- $178 Million
- Q1 2024
A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 57,556 shares of RXRX stock, worth $542,177. This represents 0.32% of its overall portfolio holdings.
Number of Shares
57,556
Previous 17,853
222.39%
Holding current value
$542,177
Previous $176,000
225.57%
% of portfolio
0.32%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
257Shares Held
191MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$232 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$227 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$151 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$116 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V710.4MShares$98 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.7B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...